Alterity Therapeutics News and Resources

Alterity Therapeutics a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, has announced it has secured binding commitments for a A$40 million capital raise through a two-tranche placement of fully paid ordinary shares to institutional and sophisticated